Khawaja Abdul Rouf, Sofi Khalid, Dar Yasir, Khateeb Muzaain, Magray Javeed, Waheed Abdul, Malik Sajad, Bhat Arif Hamid, Wani Mohd Saleem, Bhat Akbar
Department of Urology, Department of Cardiovascular surgery, Sheri Kashmir Institute of Medical Sciences (SKIMS), Srinagar Soura, Jammu and Kashmir, India.
Department of Anaesthesiology, Department of Cardiovascular surgery, Sheri Kashmir Institute of Medical Sciences (SKIMS), Srinagar Soura, Jammu and Kashmir, India.
J Kidney Cancer VHL. 2020 Jul 31;7(3):11-17. doi: 10.15586/jkcvhl.2020.149. eCollection 2020.
"To evaluate oncological and surgical outcomes of different levels of tumor thrombus and tumor characteristics secondary to renal cell carcinoma (RCC)".
Retrospective review from 2013 to 2020 of 34 patients who underwent radical nephrectomy with thrombectomy for RCC with tumor thrombus extending into the inferior vena cava (IVC) and right atrium (RA) at our center. Level I and most level II tumors were removed using straight forward occluding maneuvers with control of the contralateral renal vein. None of the patients had level III tumor extensions in our study group. For level IV thrombus, a beating heart surgery using a simplified cardiopulmonary bypass (CPB) technique was used for retrieval of thrombus from the right atrium.
" Of the 34 patients with thrombus", 19 patients had level I, 12 patients had level II, none had level III, and three patients had level IV thrombus. Two patients required simplified CPB. Another patient with level IV thrombus CPB, was not attempted in view of refractory hypotension intraoperatively. Pathological evaluation showed clear-cell carcinoma in 67.64%, papillary carcinoma in 17.64%, chromophobe in 5.8%, and squamous cell carcinoma in 8.8% of cases. Left side thrombectomy was difficult surgically, whereas right side thrombectomy did not have any survival advantage. Mean blood loss during the procedure was 325 mL, ranging from 200 to 1000 mL, and mean operative time was 185 min, ranging from 215 to 345 min. The immediate postoperative mortality was 2.9%. Level I thrombus had better survival compared to level II thrombus.
Radical nephrectomy with tumor thrombectomy remains the mainstay of treatment in RCC with inferior venacaval extension. The surgical approach and outcome depends on primary tumor size, location, level of thrombus, local invasion of IVC, any hepato-renal dysfunction or any associated comorbidities. The higher the level of thrombus, the greater is the need for prior optimization and the adoption of a multidisciplinary approach for a successful surgical outcome.
“评估肾细胞癌(RCC)继发不同程度肿瘤血栓及肿瘤特征的肿瘤学和手术结果”。
回顾性分析2013年至2020年在我院中心接受根治性肾切除术加血栓切除术治疗的34例RCC患者,其肿瘤血栓延伸至下腔静脉(IVC)和右心房(RA)。I级和大多数II级肿瘤采用直接闭塞操作并控制对侧肾静脉进行切除。本研究组中无III级肿瘤延伸患者。对于IV级血栓,采用简化体外循环(CPB)技术在心脏跳动下进行右心房血栓取出术。
“在34例有血栓的患者中”,19例为I级,12例为II级,无III级,3例为IV级血栓。2例患者需要简化CPB。另1例IV级血栓患者因术中顽固性低血压未尝试CPB。病理评估显示,67.64%为透明细胞癌,17.64%为乳头状癌,5.8%为嫌色细胞癌,8.8%为鳞状细胞癌。左侧血栓切除术手术难度大,而右侧血栓切除术无生存优势。手术过程中平均失血量为325 mL,范围为200至1000 mL,平均手术时间为185分钟,范围为215至345分钟。术后即刻死亡率为2.9%。I级血栓的生存率优于II级血栓。
根治性肾切除术加肿瘤血栓切除术仍是IVC延伸型RCC的主要治疗方法。手术方式和结果取决于原发肿瘤大小、位置、血栓程度、IVC局部侵犯情况、任何肝肾功障碍或任何合并症。血栓程度越高,术前优化及采用多学科方法以获得成功手术结果的需求就越大。